{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T04:10:03Z","timestamp":1708747803940},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11934-007-0078-5","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T15:50:24Z","timestamp":1206460224000},"page":"313-318","source":"Crossref","is-referenced-by-count":7,"title":["New therapies in chronic prostatitis"],"prefix":"10.1007","volume":"8","author":[{"given":"Nivedita Bhatta","family":"Dhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Shoskes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,26]]},"reference":[{"key":"78_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0090-4295(02)02296-3","volume":"60","author":"M.S. Litwin","year":"2002","unstructured":"Litwin MS: A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. Urology 2002, 60:14\u201318.","journal-title":"Urology"},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0022-5347(05)63957-2","volume":"169","author":"J.A. Turner","year":"2003","unstructured":"Turner JA, Ciol MA, Von Korff M, Berger R: Validity and responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2003, 169:580\u2013583.","journal-title":"J Urol"},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11136-005-1317-1","volume":"15","author":"K.J. Propert","year":"2006","unstructured":"Propert KJ, Litwin MS, Wang Y, et al.: Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 2006, 15:299\u2013305.","journal-title":"Qual Life Res"},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0022-5347(05)00233-8","volume":"175","author":"K.J. Propert","year":"2006","unstructured":"Propert KJ, McNaughton-Collins M, Leiby BE, et al.: A prospective study of symptoms and quality of life in men with chronic prostatitis\/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2006, 175:619\u2013623.","journal-title":"J Urol"},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2005.04.013","volume":"26","author":"F.M. Wagenlehner","year":"2005","unstructured":"Wagenlehner FM, Weidner W, Sorgel F, Naber KG: The role of antibiotics in chronic bacterial prostatitis. Int J Antimicrob Agents 2005, 26:1\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1439-0272.2003.tb00868.x","volume":"35","author":"K.G. Naber","year":"2003","unstructured":"Naber KG, Sorgel F: Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 2003, 35:331\u2013335.","journal-title":"Andrologia"},{"key":"78_CR7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0022-5347(05)66344-6","volume":"165","author":"J.C. Nickel","year":"2001","unstructured":"Nickel JC, Downey J, Johnston B, et al.: Predictors of patient response to antibiotic therapy for the chronic prostatitis\/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001, 165:1539\u20131544.","journal-title":"J Urol"},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003495-199958002-00021","volume":"58","author":"W. Weidner","year":"1999","unstructured":"Weidner W, Ludwig M, Brahler E, Schiefer HG: Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis. Drugs 1999, 58:103\u2013106.","journal-title":"Drugs"},{"key":"78_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(99)00142-9","volume":"14","author":"K.G. Naber","year":"2000","unstructured":"Naber KG, Busch W, Focht J: Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. Int J Antimicrob Agents 2000, 14:143\u2013149.","journal-title":"Int J Antimicrob Agents"},{"key":"78_CR10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-5347(17)42733-9","volume":"139","author":"J.F. Jimenez-Cruz","year":"1988","unstructured":"Jimenez-Cruz JF, Tormo FB, Gomez JG: Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control. J Urol 1988, 139:967\u2013970.","journal-title":"J Urol"},{"key":"78_CR11","first-page":"163","volume":"4","author":"W.L. Hu","year":"2002","unstructured":"Hu WL, Zhong SZ, He HX: Treatment of chronic bacterial prostatitis with amikacin through anal submucosal injection. Asian J Androl 2002, 4:163\u2013167.","journal-title":"Asian J Androl"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0022-5347(01)63761-3","volume":"159","author":"G.A. Barbalias","year":"1998","unstructured":"Barbalias GA, Nikiforidis G, Liatsikos EN: Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998, 159:883\u2013887.","journal-title":"J Urol"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.pcan.4500308","volume":"2","author":"D.A. Shoskes","year":"1999","unstructured":"Shoskes DA, Zeitlin SI: Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis. Prostate Cancer Prostatic Dis 1999, 2:159\u2013162.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"78_CR14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1464-410X.2005.05684.x","volume":"96","author":"M.A. Pontari","year":"2005","unstructured":"Pontari MA, McNaughton-Collins M, O\u2019Leary MP, et al.: A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 2005, 96:559\u2013565.","journal-title":"BJU Int"},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.ju.0000132798.48067.23","volume":"172","author":"D.A. Shoskes","year":"2004","unstructured":"Shoskes DA, Landis JR, Wang Y, et al.: Impact of post-ejaculatory pain in men with category III chronic prostatitis\/chronic pelvic pain syndrome. J Urol 2004, 172:542\u2013547.","journal-title":"J Urol"},{"key":"78_CR16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1442-2042.1999.06338.x","volume":"6","author":"I. Yavascaoglu","year":"1999","unstructured":"Yavascaoglu I, Oktay B, Simsek U, Ozyurt M: Role of ejaculation in the treatment of chronic non-bacterial prostatitis. Int J Urol 1999, 6:130\u2013134.","journal-title":"Int J Urol"},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1207\/s15324796abm3002_3","volume":"30","author":"P.M. Ullrich","year":"2005","unstructured":"Ullrich PM, Turner JA, Ciol M, Berger R: Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis\/pelvic pain. Ann Behav Med 2005, 30:112\u2013118.","journal-title":"Ann Behav Med"},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0022-5347(01)69361-3","volume":"169","author":"J.C. Lee","year":"2003","unstructured":"Lee JC, Muller CH, Rothman I, et al.: Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 2003, 169:587\u2013588.","journal-title":"J Urol"},{"key":"78_CR19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0090-4295(03)00583-1","volume":"62","author":"J.C. Nickel","year":"2003","unstructured":"Nickel JC, Downey J, Clark J, et al.: Levofloxacin for chronic prostatitis\/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003, 62:614\u2013617.","journal-title":"Urology"},{"key":"78_CR20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-141-8-200410190-00005","volume":"141","author":"R.B. Alexander","year":"2004","unstructured":"Alexander RB, Propert KJ, Schaeffer AJ, et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004, 141:581\u2013589.","journal-title":"Ann Intern Med"},{"key":"78_CR21","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/S0022-5347(01)64727-X","volume":"157","author":"S.A. Kaplan","year":"1997","unstructured":"Kaplan SA, Santarosa RP, D\u2019Alisera PM, et al.: Pseudodys-synergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 1997, 157:2234\u20132237.","journal-title":"J Urol"},{"key":"78_CR22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0090-4295(98)00202-7","volume":"52","author":"M.E. Mayo","year":"1998","unstructured":"Mayo ME, Ross SO, Krieger JN: Few patients with \u201cchronic prostatitis\u201d have significant bladder outlet obstruction. Urology 1998, 52:417\u2013421.","journal-title":"Urology"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0090-4295(94)90231-3","volume":"43","author":"D.E. Neal Jr","year":"1994","unstructured":"Neal DE Jr, Moon TD: Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology 1994, 43:460\u2013465.","journal-title":"Urology"},{"key":"78_CR24","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/01.ju.0000117811.40279.19","volume":"171","author":"J.C. Nickel","year":"2004","unstructured":"Nickel JC, Narayan P, McKay J, Doyle C: Treatment of chronic prostatitis\/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004, 171:1594\u20131597.","journal-title":"J Urol"},{"key":"78_CR25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000474760","volume":"22","author":"J.J. Rosette de la","year":"1992","unstructured":"de la Rosette JJ, Karthaus HF, van Kerrebroeck PE, et al.: Research in \u2018prostatitis syndromes\u2019: the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. Eur Urol 1992, 22:222\u2013227.","journal-title":"Eur Urol"},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0090-4295(01)01470-4","volume":"59","author":"M. Ishigooka","year":"2002","unstructured":"Ishigooka M, Nakada T, Hashimoto T, et al.: Spinal substance P immunoreactivity is enhanced by acute chemical stimulation of the rat prostate. Urology 2002, 59:139\u2013144.","journal-title":"Urology"},{"key":"78_CR27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0090-4295(02)02381-6","volume":"60","author":"M. Pontari","year":"2002","unstructured":"A Pontari M: Inflammation and anti-inflammatory therapy in chronic prostatitis. Urology 2002, 60:29\u201333.","journal-title":"Urology"},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-5347(05)67497-6","volume":"164","author":"R.B. Nadler","year":"2000","unstructured":"Nadler RB, Koch AE, Calhoun EA, et al.: Il-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000, 164:214\u2013218.","journal-title":"J Urol"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/j.1939-4640.2000.tb02135.x","volume":"21","author":"A.R. Shahed","year":"2000","unstructured":"Shahed AR, Shoskes DA: Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl 2000, 21:669\u2013675.","journal-title":"J Androl"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0022-5347(05)65664-9","volume":"166","author":"A.R. Shahed","year":"2001","unstructured":"Shahed AR, Shoskes DA: Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 2001, 166:1738\u20131741.","journal-title":"J Urol"},{"key":"78_CR31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000052415","volume":"39","author":"H. John","year":"2001","unstructured":"John H, Barghorn A, Funke G, et al.: Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. Eur Urol 2001, 39:72\u201378.","journal-title":"Eur Urol"},{"key":"78_CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/cs0990405","volume":"99","author":"H.F. Galley","year":"2000","unstructured":"Galley HF, Dhillon JK, Paterson RL, Webster NR: Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line. Clin Sci (Lond) 2000, 99:405\u2013410.","journal-title":"Clin Sci (Lond)"},{"key":"78_CR33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1439-0272.1993.tb02701.x","volume":"25","author":"D. Canale","year":"1993","unstructured":"Canale D, Scaricabarozzi I, Giorgi P, et al.: Use of a novel non-steroidal anti-inflammatory drug, nimesulide, in the treatment of abacterial prostatovesiculitis. Andrologia 1993, 25:163\u2013166.","journal-title":"Andrologia"},{"key":"78_CR34","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.ju.0000054983.45096.16","volume":"169","author":"J.C. Nickel","year":"2003","unstructured":"Nickel JC, Pontari M, Moon T, et al.: A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003, 169:1401\u20131405.","journal-title":"J Urol"},{"key":"78_CR35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/sti.76.5.398","volume":"76","author":"S. Bates","year":"2000","unstructured":"Bates S, Talbot M: Short course oral prednisolone therapy in chronic abacterial prostatitis and prostatodynia: case reports of three responders and one nonresponder. Sex Transm Infect 2000, 76:398\u2013399.","journal-title":"Sex Transm Infect"},{"key":"78_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-5347(05)67468-X","volume":"164","author":"G.S. Palapattu","year":"2000","unstructured":"Palapattu GS, Shoskes DA: Resolution of the chronic pelvic pain syndrome after renal transplantation. J Urol 2000, 164:127.","journal-title":"J Urol"},{"key":"78_CR37","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/01.ju.0000159198.83103.01","volume":"173","author":"J.C. Nickel","year":"2005","unstructured":"Nickel JC, Forrest JB, Tomera K, et al.: Pentosan poly-sulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 2005, 173:1252\u20131255.","journal-title":"J Urol"},{"key":"78_CR38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0090-4295(02)02383-X","volume":"60","author":"D.A. Shoskes","year":"2002","unstructured":"Shoskes DA: Phytotherapy in chronic prostatitis. Urology 2002, 60:35\u201337.","journal-title":"Urology"},{"key":"78_CR39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1464-410X.1993.tb15988.x","volume":"71","author":"E.W. Rugendorff","year":"1993","unstructured":"Rugendorff EW, Weidner W, Ebeling L, Buck AC: Results of treatment with pollen extract (cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 1993, 71:433\u2013438.","journal-title":"Br J Urol"},{"key":"78_CR40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2005.07.035","volume":"67","author":"J. Elist","year":"2006","unstructured":"Elist J: Effects of pollen extract preparation Prostat\/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis\/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology 2006, 67:60\u201363.","journal-title":"Urology"},{"key":"78_CR41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-642-46856-8_21","volume":"20","author":"P.C. Hollman","year":"1998","unstructured":"Hollman PC, Katan MB: Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl 1998, 20:237\u2013248.","journal-title":"Arch Toxicol Suppl"},{"key":"78_CR42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0014-827X(01)01111-9","volume":"56","author":"T. Guardia","year":"2001","unstructured":"Guardia T, Rotelli AE, Juarez AO, Pelzer LE: Anti-inflammatory properties of plant flavonoids: effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 2001, 56:683\u2013687.","journal-title":"Farmaco"},{"key":"78_CR43","first-page":"1680","volume":"24","author":"M. Sato","year":"1997","unstructured":"Sato M, Miyazaki T, Kambe F, et al.: Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 1997, 24:1680\u20131684.","journal-title":"J Rheumatol"},{"key":"78_CR44","first-page":"18","volume":"2","author":"D.A. Shoskes","year":"1999","unstructured":"Shoskes DA: Use of the bioflavonoid quercetin in patients with longstanding chronic prostatitis. J Am Neutraceutic Assoc 1999, 2:18\u201321.","journal-title":"J Am Neutraceutic Assoc"},{"key":"78_CR45","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0090-4295(99)00358-1","volume":"54","author":"D.A. Shoskes","year":"1999","unstructured":"Shoskes DA, Zeitlin SI, Shahed A, Rajfer J: Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999, 54:960\u2013963.","journal-title":"Urology"},{"key":"78_CR46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.ju.0000101487.83730.80","volume":"171","author":"S.A. Kaplan","year":"2004","unstructured":"Kaplan SA, Volpe MA, Te AE: A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis\/chronic pelvic pain syndrome. J Urol 2004, 171:284\u2013288.","journal-title":"J Urol"},{"key":"78_CR47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.eururo.2004.12.014","volume":"47","author":"E.B. Cornel","year":"2005","unstructured":"Cornel EB, van Haarst EP, Schaarsberg RW, Geels J: The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur Urol 2005, 47:607\u2013611.","journal-title":"Eur Urol"},{"key":"78_CR48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.ju.0000161609.31185.d5","volume":"174","author":"R.U. Anderson","year":"2005","unstructured":"Anderson RU, Wise D, Sawyer T, Chan C: Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol 2005, 174:155\u2013160.","journal-title":"J Urol"},{"key":"78_CR49","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1097\/01.ju.0000158445.68149.38","volume":"173","author":"E. Rowe","year":"2005","unstructured":"Rowe E, Smith C, Laverick L, et al.: A prospective, randomized, placebo controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. J Urol 2005, 173:2044\u20132047.","journal-title":"J Urol"},{"key":"78_CR50","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1001\/jama.285.17.2208","volume":"285","author":"K.A. Holroyd","year":"2001","unstructured":"Holroyd KA, O\u2019Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208\u20132215.","journal-title":"JAMA"},{"issue":"Suppl1","key":"78_CR51","first-page":"SI21","volume":"65","author":"E.C. Covington","year":"1998","unstructured":"Covington EC: Anticonvulsants for neuropathic pain and detoxification. Cleve Clin J Med 1998, 65(Suppl 1):SI21\u2013S129.","journal-title":"Cleve Clin J Med"},{"key":"78_CR52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2003.09.020","volume":"45","author":"I. Geramoutsos","year":"2004","unstructured":"Geramoutsos I, Gyftopoulos K, Perimenis P, et al.: Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. Eur Urol 2004, 45:333\u2013337.","journal-title":"Eur Urol"},{"key":"78_CR53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.ju.0000150062.60633.b2","volume":"173","author":"D.A. Shoskes","year":"2005","unstructured":"Shoskes, DA, Thomas, KD, Gomez, E. Anti-nanobacterial therapy for men with chronic prostatitis\/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 2005, 173:474.","journal-title":"J Urol"},{"key":"78_CR54","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/01.ju.0000055549.95490.3c","volume":"169","author":"D.A. Shoskes","year":"2003","unstructured":"Shoskes DA, Hakim L, Ghoniem G, Jackson CL: Long-term results of multi-modal therapy for chronic prostatitis\/chronic pelvic pain syndrome. J Urol 2003, 169:1406\u20131410.","journal-title":"J Urol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-007-0078-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-007-0078-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-007-0078-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T03:32:35Z","timestamp":1708745555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-007-0078-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s11934-007-0078-5","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}